GE HealthCare Anesthesia Systems Recall
potentially life-threatening risk in Volume Control Ventilation (VCV) modeGE Carestation Anesthesia Systems
GE HealthCare has issued a high-priority correction for certain Carestation anesthesia systems due to a potentially life-threatening risk when used in Volume Control Ventilation (VCV) mode.
Affected Devices
- Carestation 620, 650, 650c
- Carestation 750, 750c
These systems are used in hospitals and surgical settings for delivering anesthesia and ventilatory support to patients of all ages.
The Problem
In VCV mode, the devices affected may fail to ventilate properly. If this happens:
- Alarms and warnings will be triggered (e.g., bellows stop moving, “Unable to Drive Bellows” message, apnea alerts).
- If uncorrected, this can lead to serious injury or death from hypoxia (low oxygen levels).
What to Do
GE HealthCare recommends:
- Do NOT use VCV mode until the device is corrected.
- Use only:
- Pressure Control Ventilation (PCV)
- Pressure Control Ventilation Volume Guarantee (PCV-VG)
- Or manual ventilation
- Perform a Ventilation Screening Test on each system.
- Train your staff and ensure they are aware of the risk and temporary workaround.
- Return the Acknowledgement Form provided in the correction notice.
Questions?
Call GE HealthCare Service at 1-800-437-1171.
If your facility uses these systems, take immediate action to prevent harm. GE HealthCare is currently correcting the devices — no need to remove them from service if alternate modes are used safely.
Why Not Natural Organic Moringa Capsules Recalled
Why Not Natural Organic Moringa Capsules Recalled Over Possible Salmonella Contamination Editor's Note: This January 28 recall was the third recent moringa-root product recall, following the Sam's Super Greens recall in November and the Live it Up Super Greens recall...
Live it Up Super Greens Recalled Over Salmonella Contamination
Live it Up Super Greens Recalled Over Possible Salmonella Contamination Editor’s Note: The original recall notice was issued on January 15, 2026 and is summarized here for reference purposes. Superfoods, Inc., doing business as Live it Up (New York, NY), has issued a...
FDA Testosterone Panel Sparks Concern
Concerns Over Sudden Regulatory Shift The FDA’s December 2025 expert panel has recommended sweeping changes to testosterone regulation – a sharp departure from the agency’s long-standing cautionary stance for the hormone. The panel urged the FDA to broaden...